Clinical Trials
2 trialsNCT06745583 2026-06-03
A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients
Elixiron Immunotherapeutics (Hong Kong) Ltd.
Phase 2 Recruiting
NCT07446842 2026-03-06
Construction of AI Model for Precision Imaging Diagnosis of Cranial Diseases
Tongji Hospital
Recruiting